<DOC>
	<DOC>NCT01049347</DOC>
	<brief_summary>Activation of the hypothalamus-pituitary-adrenal system is monitored using saliva cortisol sampling during the antidepressant treatment with amitriptyline and paroxetine in moderately to severely depressed patients. Additionally, serum and plasma are sampled during the 5-week study period in order to study endocrine and metabolic parameters.</brief_summary>
	<brief_title>Amitriptyline and Paroxetine Treatment of Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Amitriptyline, perphenazine drug combination</mesh_term>
	<criteria>age: above 18 depression according DSMIV bipolar disorder substance dependency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>depression</keyword>
</DOC>